Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.
about
The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityEfflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon.Whole genome and transcriptome analyses of environmental antibiotic sensitive and multi-resistant Pseudomonas aeruginosa isolates exposed to waste water and tap water.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.High-throughput automated microfluidic sample preparation for accurate microbial genomics.Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosaEvolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland.Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Biofilm formation and antibiotic susceptibility in dispersed cells versus planktonic cells from clinical, industry and environmental origins.Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.Evolution of Cost-Free Resistance under Fluctuating Drug Selection in Pseudomonas aeruginosa.Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor.The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach.The Versatile Mutational Resistome of Pseudomonas aeruginosa.Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
P2860
Q34922676-A8D621CE-E196-4720-BB0C-6448443A236EQ34992258-3A35F764-C9C4-4768-ADB7-EEADEFDFDA27Q35062974-01E8E8CC-B7EB-47CE-A1FF-E326FD32EE20Q35482558-0FE9F794-A377-49E9-8A64-48646AF288C6Q36262179-DFBA0F1D-8283-4762-B11F-1C966271FFAAQ36300937-087E7B7F-2768-4CAA-B9D0-1A3634E38A13Q37120056-220110A5-91FE-4D7F-8F08-CF6A212F3304Q37712123-39476076-8C3F-4938-8C48-28E9D634401AQ38856197-DBEA7FA5-CFEE-43F9-A958-50FA1A779129Q38977280-936C6AE1-9222-43D8-B5D9-329717586DB4Q40056971-188524D5-2B22-4EE6-8CF6-9489010D5A7CQ40108765-BAE868E6-35B2-4246-971C-D6C8446AC737Q40559371-D58229AA-3E64-413A-AD46-DCB35DF43894Q41060499-B4D09924-86DA-4802-9CFB-5C81C05A4019Q41066625-0621632E-50FA-48FF-B4E8-F1C820122EB7Q41687386-2C12AF3A-2EFB-468A-8629-22FE71455CA7Q42659717-D7ED5680-78F0-46A3-B740-74B40E582F53Q52313185-871E5B46-24C3-4372-9CE9-BED84B179928Q59126430-DE0A99B3-63BC-4144-B24A-AE6194A2A04B
P2860
Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Quantitative contributions of ...... sa fluoroquinolone resistance.
@en
type
label
Quantitative contributions of ...... sa fluoroquinolone resistance.
@en
prefLabel
Quantitative contributions of ...... sa fluoroquinolone resistance.
@en
P2860
P50
P356
P1476
Quantitative contributions of ...... sa fluoroquinolone resistance.
@en
P2093
Bianka Nouri
P2860
P304
P356
10.1128/AAC.01581-12
P407
P577
2012-12-28T00:00:00Z